Share on Social Media:
Drug | U.S. Sales 2005 | Manufacturer | Growth in Sales | |
---|---|---|---|---|
1 | Lipitor (lowers cholesterol) | $8.2 billion | Pfizer | +13% |
2 | Zocor (controls cholesterol) | $4.4 billion | Merck | -3% |
3 | Nexium (reduces gastric acid secretion) | $4.1 billion | AstraZeneca | +19% |
4 | Prevacid (reduces gastric acid secretion) | $3.8 billion | Abbott/Takeda / TAP | -3% |
5 | Advair Diskus (management of asthma) | $3.3 billion | GlaxoSmithKline | +24% |